Home/Filings/4/0001415889-24-004016
4//SEC Filing

Gupta Rishi 4

Accession 0001415889-24-004016

CIK 0001672619other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 8:50 PM ET

Size

5.6 KB

Accession

0001415889-24-004016

Insider Transaction Report

Form 4
Period: 2024-02-13
Gupta Rishi
Director10% Owner
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-13+16,83516,835 total
    Exercise: $14.85Exp: 2034-02-12Common Stock (16,835 underlying)
Footnotes (1)
  • [F1]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2024 annual meeting of the Issuer's stockholders or (ii) the date of the 2025 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director on the applicable vesting date.

Issuer

Enliven Therapeutics, Inc.

CIK 0001672619

Entity typeother

Related Parties

1
  • filerCIK 0001537370

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 8:50 PM ET
Size
5.6 KB